Anticipation for Long Awaited Acomplia FDA Approval Likely to End by July

PRLog (Press Release) – Apr 10, 2007 – Acomplia is one of the most coveted weight loss drugs, which has benefited obese and overweight individuals in their weight loss endeavour. It has been already available in the UK, France, Ireland, Germany, Austria, Sweden, Holland, Denmark and Finland amid other countries. Some of the prospective countries to view the launch of Acomplia include Spain, Italy, and Mexico. But this popular weight loss medication Acomplia is not yet made available for use in the US weight loss market due to the stalled FDA approval.  

Ms. Joan Campbell, spokesperson of Purchase Phentermines says, “Despite its proven efficacy, Acomplia FDA approval has been for long being awaited for its launch in the huge US weight loss market”. FDA (Food and Drug Administration) has stalled the approval of Acomplia for use in the US due to certain unveiled reasons. FDA is likely to air its pending decision on Acomplia in July this year.

This weight loss drug is developed by a large-cap pharma Sanofi-Aventis. With Rimonabant as its active ingredient, Acomplia works on the principle of an appetite suppressant, which aids in the reduction of normal appetite thereby facilitating weight loss.  

Purchase Phenternmines is a dependable educative website, providing useful information pertaining to weight loss medication such as Acomplia, Phentermine, Adipex, Bontril, Didrex, Ionamin, Diethylpropion, Xenical, Tenuate, Phendimetrazine and Meridia. Phentermine benefits, how Phentermine works, obesity, weight loss programs are other set of resourceful information made available at Purchase Phentermines to help you enhance your scope of understanding. Up-to-date news, informative articles and success stories are also made available at Purchase Phentermines.  

For more information pertaining to Acomplia, visit at http://www.purchasephentermines.com/acomplia.html